Neuburgh Advisers’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$7.62M Buy
68,090
+308
+0.5% +$34.3K 0.24% 92
2019
Q2
$7.51M Buy
67,782
+4,444
+7% +$523K 0.24% 87
2019
Q1
$8.22M Buy
63,338
+25,234
+66% +$3.07M 0.28% 76
2018
Q4
$4.41M Buy
38,104
+7,480
+24% +$836K 0.17% 119
2018
Q3
$3.29M Sell
30,624
-902
-3% -$90.2K 0.11% 172
2018
Q2
$2.69M Buy
31,526
+2,376
+8% +$195K 0.09% 185
2018
Q1
$2.25M Sell
29,150
-4,114
-12% -$331K 0.08% 189
2017
Q4
$2.81M Buy
33,264
+8,778
+36% +$747K 0.1% 170
2017
Q3
$2.1M Sell
24,486
-2,288
-9% -$188K 0.08% 185
2017
Q2
$2.2M Sell
26,774
-2,024
-7% -$165K 0.08% 187
2017
Q1
$2.42M Sell
28,798
-17,006
-37% -$1.36M 0.1% 175
2016
Q4
$3.37M Buy
+45,804
New +$3.41M 0.15% 118

Other funds holding LLY

Neuburgh Advisers's LLY Position: Q3 2019 in Review

Neuburgh Advisers increased its Eli Lilly (LLY) stake by 0.45% in Q3 2019, buying an estimated $34.3K and bringing the position to 68,090 shares worth $7.62M. The position accounts for 0.24% of the portfolio, ranked #92.

Neuburgh Advisers first reported a position in LLY in Q4 2016 and has held it in 12 quarters since. The position peaked at $8.22M in Q1 2019. 1,524 funds tracked by Wall St. Rank hold LLY as of Q3 2019.

  • Neuburgh Advisers held 68,090 shares of Eli Lilly worth $7.62M as of Q3 2019.
  • Neuburgh Advisers bought 308 Eli Lilly shares in Q3 2019, an estimated $34.3K.
  • Eli Lilly made up 0.24% of Neuburgh Advisers's portfolio in Q3 2019, its #92 holding.
  • Neuburgh Advisers first reported a position in Eli Lilly in Q4 2016 and has held it in 12 quarters since.
  • Neuburgh Advisers's Eli Lilly position peaked at $8.22M in Q1 2019.
  • 1,524 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.